

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.08193858 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.08193858 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.08193858 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.08193858 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.08193858 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.08193858 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.71692095 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.57085378 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.57085378 |
| 10 | response to peptidoglycan (GO:0032494) | 4.42854697 |
| 11 | urate metabolic process (GO:0046415) | 4.29005420 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.21444730 |
| 13 | detection of other organism (GO:0098543) | 4.19963776 |
| 14 | detection of external biotic stimulus (GO:0098581) | 4.14321775 |
| 15 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.08933406 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07764895 |
| 17 | cysteine metabolic process (GO:0006534) | 4.05119093 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.04035407 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.00171589 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 4.00145324 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.00145324 |
| 22 | cellular extravasation (GO:0045123) | 3.92255326 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.91742298 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.90023368 |
| 25 | L-phenylalanine metabolic process (GO:0006558) | 3.82477915 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.82477915 |
| 27 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.78256227 |
| 28 | detection of bacterium (GO:0016045) | 3.74160498 |
| 29 | drug transmembrane transport (GO:0006855) | 3.73367416 |
| 30 | neutrophil activation (GO:0042119) | 3.72687860 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 3.72240141 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.70572913 |
| 33 | positive regulation of interferon-alpha production (GO:0032727) | 3.69876390 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.68418607 |
| 35 | glyoxylate metabolic process (GO:0046487) | 3.68370091 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.58934264 |
| 37 | response to host immune response (GO:0052572) | 3.58934264 |
| 38 | detection of biotic stimulus (GO:0009595) | 3.55943517 |
| 39 | microglial cell activation (GO:0001774) | 3.55790764 |
| 40 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.54247956 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.51792638 |
| 42 | tryptophan metabolic process (GO:0006568) | 3.50405502 |
| 43 | granulocyte activation (GO:0036230) | 3.49728432 |
| 44 | indole-containing compound catabolic process (GO:0042436) | 3.48835761 |
| 45 | indolalkylamine catabolic process (GO:0046218) | 3.48835761 |
| 46 | tryptophan catabolic process (GO:0006569) | 3.48835761 |
| 47 | sulfur amino acid catabolic process (GO:0000098) | 3.47925102 |
| 48 | drug transport (GO:0015893) | 3.46139599 |
| 49 | regulation of interferon-alpha production (GO:0032647) | 3.45728529 |
| 50 | neutrophil mediated immunity (GO:0002446) | 3.43565379 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.38139555 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37748255 |
| 53 | bile acid biosynthetic process (GO:0006699) | 3.34837326 |
| 54 | response to host (GO:0075136) | 3.33736199 |
| 55 | response to host defenses (GO:0052200) | 3.33736199 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.33736199 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 3.31971663 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.31770307 |
| 59 | protein carboxylation (GO:0018214) | 3.29573638 |
| 60 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.29573638 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.27950792 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25117866 |
| 63 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.24635599 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22839565 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.20038649 |
| 66 | complement activation, alternative pathway (GO:0006957) | 3.19700400 |
| 67 | aldehyde catabolic process (GO:0046185) | 3.17577386 |
| 68 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17378433 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17378433 |
| 70 | alpha-linolenic acid metabolic process (GO:0036109) | 3.16759350 |
| 71 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15318261 |
| 72 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.11703167 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.10571892 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.10571892 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10407672 |
| 76 | lysine metabolic process (GO:0006553) | 3.10374026 |
| 77 | lysine catabolic process (GO:0006554) | 3.10374026 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.07872177 |
| 79 | response to type I interferon (GO:0034340) | 3.06545305 |
| 80 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.04372687 |
| 81 | serine family amino acid catabolic process (GO:0009071) | 3.03349396 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02498881 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.98694442 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 2.97742659 |
| 85 | respiratory burst (GO:0045730) | 2.95994027 |
| 86 | leukocyte aggregation (GO:0070486) | 2.93839093 |
| 87 | response to interleukin-15 (GO:0070672) | 2.93587247 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93266893 |
| 89 | reverse cholesterol transport (GO:0043691) | 2.92257485 |
| 90 | urea metabolic process (GO:0019627) | 2.92122822 |
| 91 | urea cycle (GO:0000050) | 2.92122822 |
| 92 | I-kappaB phosphorylation (GO:0007252) | 2.91790519 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.89764649 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.89594316 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 2.88788589 |
| 96 | regulation of protein activation cascade (GO:2000257) | 2.87701357 |
| 97 | myeloid leukocyte mediated immunity (GO:0002444) | 2.86329032 |
| 98 | reactive oxygen species biosynthetic process (GO:1903409) | 2.85731003 |
| 99 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82326266 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81502044 |
| 101 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79867640 |
| 102 | cellular biogenic amine catabolic process (GO:0042402) | 2.79188939 |
| 103 | amine catabolic process (GO:0009310) | 2.79188939 |
| 104 | cellular response to interleukin-15 (GO:0071350) | 2.79153611 |
| 105 | leukocyte degranulation (GO:0043299) | 2.78992391 |
| 106 | regulation of mast cell activation (GO:0033003) | 2.78243063 |
| 107 | kynurenine metabolic process (GO:0070189) | 2.77695378 |
| 108 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.77639888 |
| 109 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.76836527 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 2.75901282 |
| 111 | plasma lipoprotein particle clearance (GO:0034381) | 2.75865996 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75616082 |
| 113 | amino-acid betaine metabolic process (GO:0006577) | 2.75153850 |
| 114 | regulation of complement activation (GO:0030449) | 2.74890994 |
| 115 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74525835 |
| 116 | negative regulation of interleukin-6 production (GO:0032715) | 2.73471053 |
| 117 | indolalkylamine metabolic process (GO:0006586) | 2.73373218 |
| 118 | regulation of regulatory T cell differentiation (GO:0045589) | 2.72598244 |
| 119 | cellular response to exogenous dsRNA (GO:0071360) | 2.70952128 |
| 120 | lipid oxidation (GO:0034440) | 2.70682938 |
| 121 | high-density lipoprotein particle remodeling (GO:0034375) | 2.70564683 |
| 122 | phospholipid homeostasis (GO:0055091) | 2.70403558 |
| 123 | bile acid metabolic process (GO:0008206) | 2.70304299 |
| 124 | fatty acid beta-oxidation (GO:0006635) | 2.69834838 |
| 125 | defense response to protozoan (GO:0042832) | 2.69104255 |
| 126 | negative regulation of interleukin-17 production (GO:0032700) | 2.68015408 |
| 127 | fatty acid oxidation (GO:0019395) | 2.67027944 |
| 128 | germinal center formation (GO:0002467) | 2.66916756 |
| 129 | short-chain fatty acid metabolic process (GO:0046459) | 2.66907554 |
| 130 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.66727109 |
| 131 | superoxide anion generation (GO:0042554) | 2.65699821 |
| 132 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.65588720 |
| 133 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65412907 |
| 134 | negative regulation of complement activation (GO:0045916) | 2.65075700 |
| 135 | low-density lipoprotein particle remodeling (GO:0034374) | 2.63877418 |
| 136 | protein-lipid complex remodeling (GO:0034368) | 2.63202146 |
| 137 | macromolecular complex remodeling (GO:0034367) | 2.63202146 |
| 138 | plasma lipoprotein particle remodeling (GO:0034369) | 2.63202146 |
| 139 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.63178057 |
| 140 | aromatic amino acid family metabolic process (GO:0009072) | 2.62951000 |
| 141 | macrophage activation (GO:0042116) | 2.62409223 |
| 142 | valine metabolic process (GO:0006573) | 2.62333181 |
| 143 | myeloid leukocyte activation (GO:0002274) | 2.61748458 |
| 144 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.61727364 |
| 145 | NAD biosynthetic process (GO:0009435) | 2.61415248 |
| 146 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60701094 |
| 147 | positive regulation of interferon-beta production (GO:0032728) | 2.59613252 |
| 148 | uronic acid metabolic process (GO:0006063) | 2.59413802 |
| 149 | glucuronate metabolic process (GO:0019585) | 2.59413802 |
| 150 | B cell receptor signaling pathway (GO:0050853) | 2.58926918 |
| 151 | T-helper 1 type immune response (GO:0042088) | 2.58620119 |
| 152 | regulation of leukocyte degranulation (GO:0043300) | 2.58198059 |
| 153 | B cell mediated immunity (GO:0019724) | 2.58093215 |
| 154 | negative regulation of humoral immune response (GO:0002921) | 2.57669461 |
| 155 | cellular glucuronidation (GO:0052695) | 2.57453078 |
| 156 | dendritic cell migration (GO:0036336) | 2.56794348 |
| 157 | response to muramyl dipeptide (GO:0032495) | 2.56249924 |
| 158 | regulation of tolerance induction (GO:0002643) | 2.55531872 |
| 159 | nitrogen cycle metabolic process (GO:0071941) | 2.55486030 |
| 160 | apoptotic cell clearance (GO:0043277) | 2.54772781 |
| 161 | fructose metabolic process (GO:0006000) | 2.54378500 |
| 162 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.53461526 |
| 163 | immunoglobulin mediated immune response (GO:0016064) | 2.53447827 |
| 164 | drug catabolic process (GO:0042737) | 2.53120299 |
| 165 | toxin transport (GO:1901998) | 2.51989611 |
| 166 | basic amino acid transport (GO:0015802) | 2.51940517 |
| 167 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.51307501 |
| 168 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.49626166 |
| 169 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46182097 |
| 170 | tolerance induction (GO:0002507) | 2.44123058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.07248274 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.55890166 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31139684 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.06770716 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.06005428 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.57327352 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.54036898 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06131679 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.03511760 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.00127662 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.99193907 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.82581737 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.81712558 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.64503759 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60429771 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.57810941 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55544398 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.43299715 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40160212 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.30466995 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.28064154 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25851477 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21366568 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18261218 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.11509588 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.09500864 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04826339 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.94920255 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94638561 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76660711 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75756546 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71920316 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62056650 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59939299 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59483419 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58732205 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.56235324 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55306181 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55000540 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48979145 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.47762318 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.47762318 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47415736 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43897461 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42677244 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42047533 |
| 47 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41953039 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41722541 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.40817053 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39930431 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34327097 |
| 52 | * MAF_26560356_Chip-Seq_TH1_Human | 1.34305551 |
| 53 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.33417585 |
| 54 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33224554 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31580926 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31429678 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26586654 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26469517 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24936207 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24933879 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24006730 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23737595 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22512444 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18423400 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18155450 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18115523 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17200452 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17046914 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.14797758 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12885212 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12338487 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10962973 |
| 73 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10824752 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09826195 |
| 75 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.08424138 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08137567 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06895313 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06337142 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05049573 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04306701 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02911869 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02820434 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01675119 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01437849 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97154253 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97008762 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95026497 |
| 88 | * MYB_26560356_Chip-Seq_TH2_Human | 0.94419687 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92901256 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92808277 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92586109 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92382494 |
| 93 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.91882414 |
| 94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91823493 |
| 95 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91551831 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90973606 |
| 97 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90053775 |
| 98 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88912142 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88877836 |
| 100 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87309696 |
| 101 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87101446 |
| 102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87050175 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86888048 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86193773 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85866680 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85552490 |
| 107 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84592374 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84498428 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83617001 |
| 110 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82472890 |
| 111 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82215867 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82097710 |
| 113 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82020287 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.81316157 |
| 115 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.81242699 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.80575088 |
| 117 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80297866 |
| 118 | * MYB_26560356_Chip-Seq_TH1_Human | 0.79797558 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79204965 |
| 120 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79114128 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78719346 |
| 122 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78643575 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77245171 |
| 124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76724564 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.76208462 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76102763 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.75963613 |
| 128 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75591666 |
| 129 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75136816 |
| 130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.74626750 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73754674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.05700551 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.50696143 |
| 3 | MP0005365_abnormal_bile_salt | 3.35485232 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.94308173 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.89545232 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.73551386 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.62286204 |
| 8 | MP0003195_calcinosis | 2.62052222 |
| 9 | MP0009840_abnormal_foam_cell | 2.49600239 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.48479453 |
| 11 | MP0005332_abnormal_amino_acid | 2.47341296 |
| 12 | MP0003252_abnormal_bile_duct | 2.39891044 |
| 13 | MP0003436_decreased_susceptibility_to | 2.27663363 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.27226123 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.24003469 |
| 16 | MP0002419_abnormal_innate_immunity | 2.15220728 |
| 17 | MP0003724_increased_susceptibility_to | 2.10257796 |
| 18 | MP0009785_altered_susceptibility_to | 1.97094890 |
| 19 | MP0003186_abnormal_redox_activity | 1.97010894 |
| 20 | MP0009697_abnormal_copulation | 1.90353775 |
| 21 | MP0006082_CNS_inflammation | 1.89437526 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.86559864 |
| 23 | MP0009764_decreased_sensitivity_to | 1.85332581 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.83564012 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.76190698 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.72423378 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.69872366 |
| 28 | MP0005083_abnormal_biliary_tract | 1.62145034 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.58672901 |
| 30 | MP0003828_pulmonary_edema | 1.55630750 |
| 31 | MP0008469_abnormal_protein_level | 1.55097430 |
| 32 | MP0008260_abnormal_autophagy | 1.54556122 |
| 33 | MP0005025_abnormal_response_to | 1.54436294 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.50958870 |
| 35 | MP0002132_abnormal_respiratory_system | 1.47618220 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.46621041 |
| 37 | MP0001764_abnormal_homeostasis | 1.46173130 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.44972339 |
| 39 | MP0000609_abnormal_liver_physiology | 1.44063287 |
| 40 | MP0004947_skin_inflammation | 1.43234762 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.41250481 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.40918766 |
| 43 | MP0000716_abnormal_immune_system | 1.39815181 |
| 44 | MP0008004_abnormal_stomach_pH | 1.39769821 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.39080898 |
| 46 | MP0005387_immune_system_phenotype | 1.37891302 |
| 47 | MP0001790_abnormal_immune_system | 1.37891302 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.36653592 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35970217 |
| 50 | MP0002136_abnormal_kidney_physiology | 1.31212143 |
| 51 | MP0002398_abnormal_bone_marrow | 1.30791250 |
| 52 | MP0001800_abnormal_humoral_immune | 1.30366699 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.29766730 |
| 54 | MP0003690_abnormal_glial_cell | 1.24399251 |
| 55 | MP0009384_cardiac_valve_regurgitation | 1.24181652 |
| 56 | MP0002723_abnormal_immune_serum | 1.23553015 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.22645386 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.22010980 |
| 59 | MP0006054_spinal_hemorrhage | 1.21435944 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.18702206 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.18702206 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.17256909 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.16431373 |
| 64 | MP0003303_peritoneal_inflammation | 1.15982323 |
| 65 | MP0001958_emphysema | 1.15664914 |
| 66 | MP0003866_abnormal_defecation | 1.15276183 |
| 67 | MP0001851_eye_inflammation | 1.14920652 |
| 68 | MP0005310_abnormal_salivary_gland | 1.14684701 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 1.14602292 |
| 70 | MP0002722_abnormal_immune_system | 1.14445853 |
| 71 | MP0000343_altered_response_to | 1.11797566 |
| 72 | MP0009763_increased_sensitivity_to | 1.11794937 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.11369281 |
| 74 | MP0003045_fibrosis | 1.09625635 |
| 75 | MP0005451_abnormal_body_composition | 1.08175483 |
| 76 | MP0003075_altered_response_to | 1.08063915 |
| 77 | MP0001819_abnormal_immune_cell | 1.06969947 |
| 78 | MP0002429_abnormal_blood_cell | 1.06893229 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 1.06778952 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 1.06650726 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.05565552 |
| 82 | MP0005670_abnormal_white_adipose | 1.03842232 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 1.03654643 |
| 84 | MP0002928_abnormal_bile_duct | 1.03317250 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.02880157 |
| 86 | MP0001853_heart_inflammation | 1.01766446 |
| 87 | MP0000685_abnormal_immune_system | 1.01669315 |
| 88 | MP0005671_abnormal_response_to | 1.00219677 |
| 89 | MP0000598_abnormal_liver_morphology | 0.99845529 |
| 90 | MP0003279_aneurysm | 0.99591242 |
| 91 | MP0004381_abnormal_hair_follicle | 0.99517743 |
| 92 | MP0002933_joint_inflammation | 0.99296909 |
| 93 | MP0005164_abnormal_response_to | 0.97709562 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.96187602 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.96073802 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.94956038 |
| 97 | MP0001756_abnormal_urination | 0.94679877 |
| 98 | MP0002006_tumorigenesis | 0.94679439 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.93473804 |
| 100 | MP0005166_decreased_susceptibility_to | 0.92873824 |
| 101 | MP0003448_altered_tumor_morphology | 0.91715910 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.90411225 |
| 103 | MP0005647_abnormal_sex_gland | 0.88349827 |
| 104 | MP0009278_abnormal_bone_marrow | 0.88226925 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.87289342 |
| 106 | MP0000604_amyloidosis | 0.87074689 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.86317198 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.85365844 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.84134034 |
| 110 | MP0002168_other_aberrant_phenotype | 0.83465584 |
| 111 | MP0001666_abnormal_nutrient_absorption | 0.82883689 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.82467659 |
| 113 | MP0000249_abnormal_blood_vessel | 0.82321279 |
| 114 | MP0005390_skeleton_phenotype | 0.80595147 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.79300122 |
| 116 | MP0003795_abnormal_bone_structure | 0.78739999 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.78693329 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.78556419 |
| 119 | MP0002163_abnormal_gland_morphology | 0.78312864 |
| 120 | MP0002135_abnormal_kidney_morphology | 0.77453301 |
| 121 | MP0002009_preneoplasia | 0.77084155 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.74737945 |
| 123 | MP0000371_diluted_coat_color | 0.74626554 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.72661485 |
| 125 | MP0004883_abnormal_blood_vessel | 0.72322500 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.72241525 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.72193188 |
| 128 | MP0001915_intracranial_hemorrhage | 0.71836993 |
| 129 | MP0002405_respiratory_system_inflammati | 0.71150281 |
| 130 | MP0004510_myositis | 0.70829481 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.70773647 |
| 132 | MP0000858_altered_metastatic_potential | 0.70564213 |
| 133 | MP0000689_abnormal_spleen_morphology | 0.69966874 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.69903476 |
| 135 | MP0002254_reproductive_system_inflammat | 0.69888739 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.69821982 |
| 137 | MP0004043_abnormal_pH_regulation | 0.69537309 |
| 138 | MP0004484_altered_response_of | 0.68187135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 4.70769828 |
| 2 | Myositis (HP:0100614) | 4.66326076 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 4.51549406 |
| 4 | Stomatitis (HP:0010280) | 4.43477862 |
| 5 | Optic neuritis (HP:0100653) | 4.43457425 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.43457425 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.14798725 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.14798725 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.14798725 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.02038902 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.01080487 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.92420421 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.91004444 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.80399163 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.75096902 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.65115742 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.48013049 |
| 18 | Xanthomatosis (HP:0000991) | 3.41370429 |
| 19 | Joint hemorrhage (HP:0005261) | 3.34026616 |
| 20 | Hyperglycinuria (HP:0003108) | 3.33772921 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.33483119 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.26115891 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.23202866 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.23202866 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.22197699 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 3.19335301 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.17683157 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.16680293 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.14692793 |
| 30 | Abnormality of proline metabolism (HP:0010907) | 3.11477610 |
| 31 | Hydroxyprolinuria (HP:0003080) | 3.11477610 |
| 32 | T lymphocytopenia (HP:0005403) | 3.10855230 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.10737004 |
| 34 | Mucopolysacchariduria (HP:0008155) | 3.10737004 |
| 35 | Complement deficiency (HP:0004431) | 3.09949108 |
| 36 | Hyperglycinemia (HP:0002154) | 3.09459345 |
| 37 | Myocardial infarction (HP:0001658) | 3.07882049 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.06395462 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.04367140 |
| 40 | Glomerulonephritis (HP:0000099) | 3.02354307 |
| 41 | Eczematoid dermatitis (HP:0000976) | 3.01329781 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.99402288 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.98753201 |
| 44 | Episodic fever (HP:0001954) | 2.96847985 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.94049891 |
| 46 | Arterial thrombosis (HP:0004420) | 2.92184013 |
| 47 | Vasculitis (HP:0002633) | 2.92023597 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.87561195 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.87561195 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.87561195 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87403622 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87403622 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.87110179 |
| 54 | Deep venous thrombosis (HP:0002625) | 2.86002876 |
| 55 | Petechiae (HP:0000967) | 2.85371091 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.80014963 |
| 57 | Obstructive lung disease (HP:0006536) | 2.80014963 |
| 58 | Meningitis (HP:0001287) | 2.79384131 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.79074165 |
| 60 | Hyperammonemia (HP:0001987) | 2.75993367 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.73920499 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.73646886 |
| 63 | Ketosis (HP:0001946) | 2.70990657 |
| 64 | Epistaxis (HP:0000421) | 2.63853389 |
| 65 | Peritonitis (HP:0002586) | 2.62970356 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.61393044 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.61046557 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.60919911 |
| 69 | Hyperlipoproteinemia (HP:0010980) | 2.59623982 |
| 70 | Abnormality of the common coagulation pathway (HP:0010990) | 2.59339339 |
| 71 | Abnormality of complement system (HP:0005339) | 2.58785601 |
| 72 | Encephalitis (HP:0002383) | 2.58653622 |
| 73 | Hemoptysis (HP:0002105) | 2.55797156 |
| 74 | Increased CSF protein (HP:0002922) | 2.54385910 |
| 75 | Chest pain (HP:0100749) | 2.53423869 |
| 76 | Esophageal varix (HP:0002040) | 2.53413624 |
| 77 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51672678 |
| 78 | Anorexia (HP:0002039) | 2.51123489 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51073535 |
| 80 | Axonal loss (HP:0003447) | 2.50591923 |
| 81 | Loss of speech (HP:0002371) | 2.50430438 |
| 82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.49450576 |
| 83 | Progressive neurologic deterioration (HP:0002344) | 2.48102491 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.46581720 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 2.44188946 |
| 86 | Epidermoid cyst (HP:0200040) | 2.43288371 |
| 87 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41130229 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 2.40071027 |
| 89 | Fat malabsorption (HP:0002630) | 2.37338708 |
| 90 | Enlarged kidneys (HP:0000105) | 2.37311218 |
| 91 | Pulmonary embolism (HP:0002204) | 2.37287697 |
| 92 | Abnormality of the intrinsic pathway (HP:0010989) | 2.35803096 |
| 93 | Nephritis (HP:0000123) | 2.35382753 |
| 94 | Recurrent skin infections (HP:0001581) | 2.35214991 |
| 95 | Leukocytosis (HP:0001974) | 2.33367203 |
| 96 | Abnormality of T cells (HP:0002843) | 2.32724362 |
| 97 | Nausea (HP:0002018) | 2.30503217 |
| 98 | Recurrent viral infections (HP:0004429) | 2.29419727 |
| 99 | Increased IgE level (HP:0003212) | 2.27782756 |
| 100 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26511906 |
| 101 | Gangrene (HP:0100758) | 2.23090495 |
| 102 | Hypoalphalipoproteinemia (HP:0003233) | 2.22201515 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.22103812 |
| 104 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22103812 |
| 105 | Chronic diarrhea (HP:0002028) | 2.18831610 |
| 106 | Anomalous pulmonary venous return (HP:0010772) | 2.17491609 |
| 107 | Purpura (HP:0000979) | 2.17078866 |
| 108 | Abnormality of T cell physiology (HP:0011840) | 2.14436579 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 2.12581764 |
| 110 | Glycosuria (HP:0003076) | 2.12581764 |
| 111 | Gingival bleeding (HP:0000225) | 2.11245059 |
| 112 | Joint swelling (HP:0001386) | 2.09024617 |
| 113 | Ketoacidosis (HP:0001993) | 2.08999941 |
| 114 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05902617 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 2.05579463 |
| 116 | Tetraparesis (HP:0002273) | 2.05516466 |
| 117 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05485514 |
| 118 | Hypobetalipoproteinemia (HP:0003563) | 2.04890229 |
| 119 | Hypolipoproteinemia (HP:0010981) | 2.04487933 |
| 120 | Pustule (HP:0200039) | 2.02503799 |
| 121 | Hypochromic microcytic anemia (HP:0004840) | 2.02307557 |
| 122 | Polyneuropathy (HP:0001271) | 2.02274302 |
| 123 | Acne (HP:0001061) | 2.01772030 |
| 124 | Abnormality of the pleura (HP:0002103) | 2.01638374 |
| 125 | Vascular calcification (HP:0004934) | 2.00641389 |
| 126 | Periodontitis (HP:0000704) | 1.99831811 |
| 127 | Osteomyelitis (HP:0002754) | 1.99742684 |
| 128 | Steatorrhea (HP:0002570) | 1.99000300 |
| 129 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98486745 |
| 130 | Abnormality of serum amino acid levels (HP:0003112) | 1.98240980 |
| 131 | Abnormality of methionine metabolism (HP:0010901) | 1.98035826 |
| 132 | Symptomatic seizures (HP:0011145) | 1.98024967 |
| 133 | Gingivitis (HP:0000230) | 1.97854584 |
| 134 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.97339622 |
| 135 | Inflammation of the large intestine (HP:0002037) | 1.96259047 |
| 136 | Acute hepatic failure (HP:0006554) | 1.95622158 |
| 137 | Recurrent bronchitis (HP:0002837) | 1.94648351 |
| 138 | Granulocytopenia (HP:0001913) | 1.93531015 |
| 139 | Thrombophlebitis (HP:0004418) | 1.93386995 |
| 140 | Pathologic fracture (HP:0002756) | 1.93151486 |
| 141 | Hematochezia (HP:0002573) | 1.92759723 |
| 142 | Abnormality of the pericardium (HP:0001697) | 1.91739857 |
| 143 | Hypercholesterolemia (HP:0003124) | 1.90473244 |
| 144 | Protuberant abdomen (HP:0001538) | 1.89276192 |
| 145 | Papilledema (HP:0001085) | 1.88540179 |
| 146 | Mediastinal lymphadenopathy (HP:0100721) | 1.88409957 |
| 147 | Abnormality of the lumbar spine (HP:0100712) | 1.87971567 |
| 148 | Eosinophilia (HP:0001880) | 1.87509308 |
| 149 | Abnormality of the pulmonary veins (HP:0011718) | 1.87166974 |
| 150 | Renal tubular acidosis (HP:0001947) | 1.87132193 |
| 151 | Urticaria (HP:0001025) | 1.87036825 |
| 152 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86607810 |
| 153 | Cellulitis (HP:0100658) | 1.86502694 |
| 154 | Albinism (HP:0001022) | 1.85029356 |
| 155 | Subacute progressive viral hepatitis (HP:0006572) | 1.84177144 |
| 156 | Methylmalonic aciduria (HP:0012120) | 1.82783570 |
| 157 | Cardiovascular calcification (HP:0011915) | 1.82622589 |
| 158 | Keratitis (HP:0000491) | 1.82298264 |
| 159 | Abnormal tarsal ossification (HP:0008369) | 1.82286077 |
| 160 | Metabolic acidosis (HP:0001942) | 1.81945216 |
| 161 | Hypergammaglobulinemia (HP:0010702) | 1.81574020 |
| 162 | Polyuria (HP:0000103) | 1.79624685 |
| 163 | Amyloidosis (HP:0011034) | 1.79224934 |
| 164 | Microcytic anemia (HP:0001935) | 1.78913081 |
| 165 | Gout (HP:0001997) | 1.78410517 |
| 166 | Disinhibition (HP:0000734) | 1.77977287 |
| 167 | Alkalosis (HP:0001948) | 1.77483859 |
| 168 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.77382912 |
| 169 | Sensorimotor neuropathy (HP:0007141) | 1.76955255 |
| 170 | Hepatosplenomegaly (HP:0001433) | 1.76137334 |
| 171 | Vertigo (HP:0002321) | 1.74942874 |
| 172 | Gastrointestinal inflammation (HP:0004386) | 1.74698194 |
| 173 | Recurrent pneumonia (HP:0006532) | 1.73777287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.57458818 |
| 2 | TGFBR2 | 2.82715824 |
| 3 | MAP3K14 | 2.66415887 |
| 4 | MAP2K3 | 2.53858057 |
| 5 | ERN1 | 2.47236236 |
| 6 | NUAK1 | 2.39374429 |
| 7 | TAOK3 | 2.32784063 |
| 8 | INSRR | 2.31577049 |
| 9 | MST4 | 2.24869199 |
| 10 | FLT3 | 2.21429588 |
| 11 | TEC | 2.20621447 |
| 12 | IRAK4 | 2.20012863 |
| 13 | PBK | 2.14468647 |
| 14 | RIPK4 | 2.08848247 |
| 15 | STK38L | 2.05874973 |
| 16 | MAP3K2 | 2.00106175 |
| 17 | TYK2 | 1.96933250 |
| 18 | EPHB1 | 1.94775968 |
| 19 | WNK3 | 1.87654328 |
| 20 | MUSK | 1.84519077 |
| 21 | KIT | 1.83912385 |
| 22 | TBK1 | 1.79162562 |
| 23 | GRK7 | 1.78716096 |
| 24 | BCKDK | 1.77101390 |
| 25 | FES | 1.75747996 |
| 26 | KDR | 1.70522960 |
| 27 | TIE1 | 1.64348405 |
| 28 | GRK6 | 1.63145443 |
| 29 | ZAK | 1.62572055 |
| 30 | PIK3CG | 1.56774654 |
| 31 | TNK2 | 1.47348907 |
| 32 | BRD4 | 1.46190065 |
| 33 | CSK | 1.43560720 |
| 34 | FGFR3 | 1.43284098 |
| 35 | CSF1R | 1.36392807 |
| 36 | MAP3K13 | 1.35993488 |
| 37 | STK10 | 1.34977929 |
| 38 | TAOK1 | 1.33295074 |
| 39 | TXK | 1.32190238 |
| 40 | BMPR2 | 1.31944255 |
| 41 | WNK4 | 1.29267985 |
| 42 | NEK9 | 1.29162750 |
| 43 | FGR | 1.28410455 |
| 44 | TRPM7 | 1.26620148 |
| 45 | MAP4K1 | 1.24961262 |
| 46 | MAP3K1 | 1.22665709 |
| 47 | IKBKB | 1.22248412 |
| 48 | JAK1 | 1.21474442 |
| 49 | CDK12 | 1.20209690 |
| 50 | MAP3K12 | 1.15567085 |
| 51 | BTK | 1.14982693 |
| 52 | CAMK1D | 1.10795240 |
| 53 | JAK3 | 1.08557666 |
| 54 | MAP2K6 | 1.07602662 |
| 55 | EPHA3 | 1.02174746 |
| 56 | PTK2B | 1.01573320 |
| 57 | PRPF4B | 0.99912231 |
| 58 | LATS1 | 0.96578581 |
| 59 | OXSR1 | 0.92243803 |
| 60 | LYN | 0.88115992 |
| 61 | STK3 | 0.87116013 |
| 62 | SIK1 | 0.85871066 |
| 63 | ERBB4 | 0.85357171 |
| 64 | FRK | 0.85044419 |
| 65 | AKT3 | 0.83708893 |
| 66 | EIF2AK3 | 0.83400818 |
| 67 | SIK3 | 0.82866164 |
| 68 | HIPK2 | 0.82611212 |
| 69 | EIF2AK2 | 0.82575424 |
| 70 | BMPR1B | 0.82440239 |
| 71 | YES1 | 0.80213358 |
| 72 | FER | 0.79356895 |
| 73 | PIK3CA | 0.79041815 |
| 74 | LRRK2 | 0.78916497 |
| 75 | BLK | 0.78890271 |
| 76 | IRAK1 | 0.75282081 |
| 77 | CAMKK2 | 0.75056797 |
| 78 | MAP3K11 | 0.74902127 |
| 79 | STK4 | 0.73804482 |
| 80 | JAK2 | 0.73405063 |
| 81 | DMPK | 0.72265437 |
| 82 | ACVR1B | 0.72182465 |
| 83 | IKBKE | 0.71329035 |
| 84 | PDK1 | 0.69914248 |
| 85 | MAP4K2 | 0.69342077 |
| 86 | IGF1R | 0.68947314 |
| 87 | ZAP70 | 0.68205956 |
| 88 | MAP3K3 | 0.67139522 |
| 89 | PIM2 | 0.66921810 |
| 90 | PIM1 | 0.66758133 |
| 91 | IRAK2 | 0.66301593 |
| 92 | MAP3K6 | 0.64674883 |
| 93 | STK24 | 0.64377410 |
| 94 | MST1R | 0.63008454 |
| 95 | PRKAA2 | 0.62779947 |
| 96 | MAP3K5 | 0.62587139 |
| 97 | SGK2 | 0.62539185 |
| 98 | CDK6 | 0.62486449 |
| 99 | PRKD2 | 0.61716221 |
| 100 | KSR2 | 0.60093795 |
| 101 | MAPK7 | 0.59575186 |
| 102 | TAOK2 | 0.59178901 |
| 103 | MAPK11 | 0.58163076 |
| 104 | MAP3K7 | 0.56750092 |
| 105 | PDPK1 | 0.56738595 |
| 106 | CLK1 | 0.56617769 |
| 107 | ABL2 | 0.56390140 |
| 108 | FGFR4 | 0.54646542 |
| 109 | CHUK | 0.53412855 |
| 110 | MOS | 0.52344517 |
| 111 | HCK | 0.51654492 |
| 112 | LCK | 0.51335682 |
| 113 | GRK1 | 0.50769394 |
| 114 | MET | 0.50741565 |
| 115 | ITK | 0.50201101 |
| 116 | PTK6 | 0.48989835 |
| 117 | SYK | 0.48010618 |
| 118 | PRKCQ | 0.47578911 |
| 119 | SGK3 | 0.47384790 |
| 120 | RPS6KA4 | 0.46836960 |
| 121 | DAPK2 | 0.46709252 |
| 122 | NLK | 0.46654086 |
| 123 | EPHA2 | 0.45835317 |
| 124 | MAPK15 | 0.44907925 |
| 125 | STK38 | 0.44547590 |
| 126 | MARK3 | 0.44137620 |
| 127 | WNK1 | 0.42894645 |
| 128 | ABL1 | 0.41861953 |
| 129 | EGFR | 0.40494623 |
| 130 | ADRBK2 | 0.40494252 |
| 131 | MAPKAPK2 | 0.38636252 |
| 132 | MELK | 0.38491110 |
| 133 | PRKCD | 0.37641512 |
| 134 | MATK | 0.36873558 |
| 135 | GSK3A | 0.36721509 |
| 136 | FYN | 0.35071532 |
| 137 | PAK3 | 0.30537753 |
| 138 | STK11 | 0.29359925 |
| 139 | RAF1 | 0.29282230 |
| 140 | CDC42BPA | 0.29046444 |
| 141 | MAPK12 | 0.28938893 |
| 142 | PRKG2 | 0.27509422 |
| 143 | PINK1 | 0.27368688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.25574416 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.24202901 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.81835199 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.70224579 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60016444 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.56716388 |
| 7 | Peroxisome_Homo sapiens_hsa04146 | 2.44674872 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38924461 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.04251288 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.04110363 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.02647069 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99192371 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99045834 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93816441 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91564774 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91115997 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.88858774 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.81565894 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78933953 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.75837741 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73507119 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.72425627 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72358786 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67248372 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63017429 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62208506 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59395837 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.57861552 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57376066 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55766645 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51816849 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50837445 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45702015 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42846905 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41865738 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41850886 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36144318 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34962444 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33809618 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32999786 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32132205 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31998747 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31157602 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28751035 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27544381 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26613790 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21011489 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.15155669 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.14411699 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12226079 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12162892 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11142803 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.10822625 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.09931786 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09676217 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06745523 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.06036516 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05123925 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04957162 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04214037 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.04094522 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02512595 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01146930 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99452613 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99387986 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.99321110 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99138211 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98527000 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96125120 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95483678 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.94897432 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.92385037 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.89665531 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.87134825 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86767289 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86267185 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86127629 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.83873520 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81274556 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.80950145 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79898179 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79604443 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78707521 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78404822 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76755489 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76355449 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75808579 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.75784787 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75700270 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75232317 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.72726278 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72311165 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71768232 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71676120 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71269125 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69275441 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69195081 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68552751 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68061058 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67969007 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67880682 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67767430 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.65530615 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63269514 |
| 105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63213839 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62195620 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62162372 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.61812655 |
| 109 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61229149 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60646135 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60556723 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60109218 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.58813427 |
| 114 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58036549 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54420407 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53543075 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52616338 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52516430 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.52230163 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52026340 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50890243 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50798812 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49812027 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49765226 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.49580249 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48307471 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.47831357 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47294205 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46783380 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46685366 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46326296 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44738803 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44331301 |
| 134 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43169247 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42566472 |
| 136 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41952375 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40553569 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39720302 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39112037 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38744610 |
| 141 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37042923 |
| 142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35872879 |
| 143 | Influenza A_Homo sapiens_hsa05164 | 0.35669967 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35236793 |
| 145 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34951971 |
| 146 | Mineral absorption_Homo sapiens_hsa04978 | 0.33528493 |
| 147 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33092281 |
| 148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32705342 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32194041 |
| 150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31692124 |
| 151 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29933254 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29614426 |
| 153 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25172205 |

